Scarica l'app Stockscreener
3.88
14.79%
0.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Ardelyx Inc Borsa (ARDX) Ultime notizie
The Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Benign Growth For Ardelyx, Inc. (NASDAQ:ARDX) Underpins Stock's 28% Plummet - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - Bluefield Daily Telegraph
Investors Who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Investors who Lost Money on Ardelyx, Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationARDX - ACCESS Newswire
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Ardelyx, Inc. (ARDX) - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ardelyx, Inc. (ARDX) - ACCESS Newswire
David Mott Bought 19% More Shares In Ardelyx - simplywall.st
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx, Inc. Class Action: Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Ardelyx, Inc.(ARDX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
Investors who lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Ardelyx, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationARDX - ACCESS Newswire
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire
Ardelyx, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsARDX - ACCESS Newswire
(ARDX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ardelyx downgraded at Raymond James after Q1 sales miss - MSN
Ardelyx presents data supporting IBSRELA at DDW 2025 - TipRanks
Ardelyx First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Hedge Fund and Insider Trading News: Paul Tudor Jones, Warren Buffett, John Paulson Bill Ackman, Platinum Asset Management, Ardelyx Inc (ARDX), Stem Inc (STEM), and More - Insider Monkey
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digesti - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Diseas - GuruFocus
Ardelyx (ARDX) Highlights IBSRELA's Efficacy at Digestive Disease Week Conference | ARDX Stock News - GuruFocus
Ardelyx showcases IBSRELA data at Digestive Disease Week - Investing.com Australia
Ardelyx showcases IBSRELA data at Digestive Disease Week By Investing.com - Investing.com South Africa
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference - TradingView
Triple Study Results: IBSRELA IBS-C Drug Proves Safe for Teens and Nursing Mothers at DDW 2025 - Stock Titan
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Inc Reports Strong Growth Amid Challenges - MSN
Ardelyx targets $240M-$250M in IBSRELA 2025 sales amid strong Q1 growth - MSN
Analysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest Report - Yahoo Finance
Raymond James cuts Ardelyx stock rating, lowers target to $11 By Investing.com - Investing.com Canada
Ardelyx (ARDX) Price Target Lowered by Citigroup to $10.00 | ARDX Stock News - GuruFocus
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc.(ARDX) Shareholders - ACCESS Newswire
Ardelyx Inc earnings missed by $0.06, revenue fell short of estimates - Investing.com Australia
Raymond James cuts Ardelyx stock rating, lowers target to $11 - Investing.com Australia
Ardelyx (ARDX) Faces Downgrade Amid Revenue Shortfall - GuruFocus
Ardelyx's Q1 Loss Widens; Shares Fall - marketscreener.com
Ardelyx stock downgraded at Raymond James (ARDX:NASDAQ) - Seeking Alpha
Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty (NASDAQ:ARDX) - Seeking Alpha
Stocks in play: SECURE Waste Infrastructure Corp. - The Globe and Mail
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13 - marketscreener.com
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | - GuruFocus
Ardelyx (ARDX) Price Target Reduced by Citi After Q1 Report | AR - GuruFocus
Ardelyx (ARDX) Downgraded by Raymond James Amid Sales Concerns | ARDX Stock News - GuruFocus
Ardelyx (ARDX) Price Target Reduced by Citi After Q1 Report | ARDX Stock News - GuruFocus
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):